Inventor

GRYAZNOV SERGEI M

US47 patents

⚠️ This page may combine multiple inventors who share the name “GRYAZNOV SERGEI M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GRYAZNOV SERGEI M

LYNX THERAPEUTICS INC

Oligonucleotide N3′→N5′Phosphoramidate Duplexes

Oligonucleotide N3&#39;→P5&#39; phosphoramidates

Oligonucleotide N3&#39;-P5&#39; phosphoramidates: hybridization and nuclease resistance properties

Oligodeoxyribonucleotide N3&#39; P5&#39; phosphoramidates

Oligonucleotide N3&#39;→P5&#39; phosphoramidates: hybridization and nuclease resistance properties

Oligonucleotide N3&#39;-P5&#39; phosphoramidates: hybridization and nuclease resistance properties

Oligonucleotide N3→P5&#39; phosphoramidates: triplex DNA formation

Adaptor-based sequence analysis

Adaptor-based sequence analysis

Convergent synthesis of branched and multiply connected macromolecular structures

Auto-ligating oligonucleotide compounds

Convergent synthesis of branched and multiply connected macromomolecular structures

Oligonucleotide clamps having diagnostic and therapeutic applications

Oligonucleotide clamps

Oligonucleotide clamps having diagnostic applications

Solid phase synthesis of oligonucleotide N3&#39;-P5&#39; phosphoramidates

Oligonucleotide clamps having diagnostic and therapeutic applications

Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates

GERON CORP

Synthesis of protected 3′-amino nucleoside monomers

Oligonucleotide conjugates

2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use

Guanine analogs as telomerase substrates and telomere length affectors

C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

Guanine analogs as telomerase substrates and telomere length affectors

Synthesis of protected 3′-amino nucleoside monomers

Synthesis of protected 3′-amino nucleoside monomers

Guanine analogs as telomerase substrates and telomere length affectors

2′-arabino-fluorooligonucleotide N3′˜P5′ phosphoramidates: their synthesis and use

Guanine analogs as telomerase substrates and telomere length affectors

2′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use

Guanine analogs as telomerase substrates and telomere length affectors

Oligonucleotide conjugates

Synthesis of protected 3′-amino nucleoside monomers

C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders

UNIV NORTHWESTERN

Oligodeoxyribonucleotides including 3&#39;-aminonucleoside-phosphoramidate linkages and terminal 3&#39;-amino groups

Non-enzymatic ligation of oligonucleotides

Method for covalently linking adjacent oligonucleotides

Oligonucleotides having modified internucleoside linkages or terminal amino group

Process for making oligonucleotides having modified internucleoside linkages

GRYAZNOV SERGEI M

Oligonucleotide conjugates

Synthesis of protected 3′-amino nucleoside monomers

Compounds having anti-adhesive effects on cancer cells

Compounds having anti-adhesive effects on cancer cells

PERKIN ELMER CORP APPLIED BIOS

Enzymatic ligation of 3&#39;amino-substituted oligonucleotides

(unassigned)

Oligonucleotides having modified internucleoside linkages

UNIV TEXAS

Telomerase mediated telomere altering compounds

UNIV ROCHESTER

Methods and compositions for inhibition of RNA splicing

Oligonucleotide N3'→P5' phosphoramidates

Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties

Oligodeoxyribonucleotide N3' P5' phosphoramidates

Oligonucleotide N3'→P5' phosphoramidates: hybridization and nuclease resistance properties

Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties

Oligonucleotide N3→P5' phosphoramidates: triplex DNA formation

Solid phase synthesis of oligonucleotide N3'-P5' phosphoramidates

Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups

Enzymatic ligation of 3'amino-substituted oligonucleotides